Photo of Steven Frank from MD Anderson Cancer Center/X
Jun 5, 2024, 06:48
The results of this multi-center Phase III randomized trial by Steven Frank – MD Anderson Cancer Center
MD Anderson Cancer Center shared on X/Twitter:
” ‘The results of this multi-center Phase III randomized trial provide evidence for intensity modulated proton therapy as a new standard-of-care treatment approach for the management of head and neck tumors,’ says our Steven Frank of research presented at ASCO24. (Abstract 6006).”
Source: MD Anderson Cancer Center/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 2, 2024, 12:12
Nov 2, 2024, 12:09
Nov 2, 2024, 11:23
Nov 2, 2024, 10:52
Nov 2, 2024, 10:50